Recital 4, Regulation (EU) 2024/2699

In forcesince 18 Oct 2024

Under Article 7(4) of Regulation (EU) 2021/2282, the Commission, after seeking a recommendation from the Coordination Group, is to adopt a decision, by means of an implementing act and at least every 2 years, selecting the medical devices and in vitro diagnostic medical devices referred to in Article 7(1), points (c) and (d), of Regulation (EU) 2021/2282 for joint clinical assessment. For the purposes of such selection, it is necessary to ensure that the HTA secretariat regularly receives from the European Medicines Agency the list of those medical devices and in vitro diagnostic medical devices.